SCAI is the only professional medical society in the U.S. dedicated solely to interventional cardiology. We provide the tools and resources you need at each stage of your career to deliver the best patient care. From providing you with clinical guidelines, education, and representation to professional recognition and research opportunities, wherever you are located around the world, SCAI is your home.

Topics: 

– 01 SafeFemoral
– 02 ACHD Starts Young
– 03 Acute and Chronic Thromboembolic Pulmonary Disease
– 04 Advocacy 101
– 05 Advocacy in Interventional Cardiology – Joseph Babb Memorial Symposium
– 06 Algorithms for Challenging Cath Lab Scenarios – A Case-Based Approach
– 07 Aorto-Illiac Disease – Case-Based Approach
– 08 Best Cases at SCAI 2020
– 09 Best Complex Structural Cases
– 10 Best Coronary Complications Cases
– 11 The Best of Catheterization and Cardiovascular Interventions 2019
– 12 The Best of Circulation Cardiovascular Interventions 2019
– 13 Best of JACC Cardiovascular Interventions
– 14 Best of Quality Tip-of-the-Month
– 15 Best Peripheral Complications Cases
– 16 Cardiogenic Shock
– 17 Cardiovascular Professionals Symposium – Antithrombotic Pharmacology
– 18 Cardiovascular Professionals Symposium Growing a Structural Heart Program
– 19 Cardiovascular Professionals Symposium Hemodynamics and SHOCK
– 20 Carotid Artery Disease (CEAStentingMedical Therapy)
– 21 Case-Based Approach to SFA (Superficial Femoral Artery)
– 22 Cases Over Cocktails
– 23 Cath Conference – Case-Based Discussion
– 24 CHD Community Forum
– 25 CHD Late Breaking Science
– 26 Chronic Total Occlusion (CTO) – Current Approaches
– 27 Presidential Inauguration and Member Induction, FSCAI _ MSCAI Recognition
– 28 Complication Management
– 29 Congenital Heart Disease Cases
– 30 Controversy! Transcatheter Aortic Valve Replacement
– 31 Conversations with Masters
– 32 COVID-19 and Mechanical Circulatory Support
– 33 COVID-19 Session Perspectives From the Front Lines of the Pandemic
– 34 Critical Limb Ischemia (CLI)
– 35 Cutting-Edge Medical Therapy for Peripheral Vascular Disease
– 36 Emerging Technologies in the Peripheral Space
– 37 Essential Skills for the Structuralist
– 38 Featured Clinical Research
– 39 Fundamentals of PFO Therapy
– 40 Harnessing the Power of Social Media
– 41 A Healthy and Diverse Cath Lab Charles Chambers Memorial Symposium
– 42 High-Risk and Complex PCI
– 43 How the Guidelines Apply to Real Life – Case Based
– 44 Hypercoagulability and Antithrombotic Recommendations During the COVID-19 Pandemic
– 45 Imaging – When and How And What Am I Looking At
– 46 Interventional Cardio-Oncology
– 47 Interventional Life, Part I – How To
– 48 Interventional Life, Part II – Getting Things Done
– 49 Intravenous Platelet Inhibition in PCI – Case-Based Look at Expanding Applications
– 50 Keys for a Successful Left Atrial Appendage Program
– 51 LDL Management for the Interventionalist
– 52 Learning From the Past
– 53 Left Atrial Occlusion and PFO Closure – Clinical Update
– 54 Left Main Strategies
– 55 Left Main Strategies
– 56 Lessons from the ISCHEMIA Trial
– 57 The Low-Risk TAVR Patient – Considerations in 2020
– 58 Management of Calcified Lesions – Atherectomy and Intravascular Lithotripsy
– 59 Management of Complex Coronary Lesions—Optimizing cPCI in a Dynamic Environment
– 60 Management of the cPCI Patient – CTO, Bifurcations, and High Bleeding Risk
– 61 Mullin_s Lecture
– 62 The New Frontier of Transcatheter Tricuspid Interventions
– 63 Oh My Goodness – Pulmonary Vein Stenosis
– 64 Oh My! Obstruction and Rupture
– 65 Oops! How to Stay Out of Trouble – A Primer on Complications
– 66 Oral Abstracts – Focus on the Patent Arterial Duct
– 67 Other Stuff That Does Not Go Well
– 68 Paravalvular Regurgitation – Plug the Hole
– 69 PCI Management of Complex Anatomic Subsets
– 70 Peripheral Vascular Interventions How the Guidelines Apply to Real Life
– 71 Peripheral Vascular Interventions – State Of the Art
– 72 Physiology-Guided PCI
– 73 Planning Complicated Interventions and Dealing With Unpredictable Complications
– 74 Polyvascular Disease, Secondary Prevention in PVI Patients With PVD
– 75 Programmatic and Technological Innovations in the Cath Lab
– 76 Protocol-Based Care and Opportunities for Standardization
– 77 Psychology of the Interventional Cardiologist
– 78 Quality – The Good, the Bad, and the Ugly
– 79 Robotic PCI
– 80 SCAI Clinical Documents
– 81 SCAI Complex Peripheral Vascular Interventions (SCAI-CPVI) Summit – Interactive Case Discussions
– 82 SCAI Town Hall with Q_A
– 83 SCAI TRAnsition for VALUE
– 84 SCAI Women in Innovations (SCAI-WIN) Symposium
– 85 SCAI Women in Innovations (SCAI-WIN) Symposium
– 86 SCAI Women in Innovations (SCAI-WIN) Coronary Artery Disease and Interventions— Sex Considerations
– 87 SCAI-ACC Joint Session Cath Lab Economics
– 88 SCAI-CRF Joint Session PCI State of the Art— A Case-Based Review
– 89 Structural Heart Program Building and Management
– 90 TAVR in the COVID-19 Era and Beyond
– 91 Transcatheter Mitral Repair – Simplifying Expanded Indications
– 92 Transcatheter Mitral Replacement – Today and Tomorrow
– 93 Transcatheter Mitral Replacement – Today and Tomorrow
– 94 Transcatheter Mitral Valve Repair and Replacement Selection, Therapy, and Outcomes
– 95 TRIP – Radial Access and Beyond
– 96 The Tsunami of TAVR – Translating the Science Into Practice for All Patients
– 97 Welcome
– 98 What the Imager Can and Should Tell the Proceduralist